Lexicon Pharmaceuticals

biopharmaceutical company

LXRX Nasdaq ISIN US5288723027 SEC CIK 1062822
Follow Lexicon Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $11.3M −20.7% vs same quarter last year
Net income −$14M −9.7% vs same quarter last year
EPS, diluted −$0.03 +25% vs same quarter last year
Operating cash flow −$8.1M +66.1% vs same quarter last year
Revenue by quarter
$1.6M
$1.3M
$28.9M
$14.2M
$5.5M
$21.1M
$692K
$11.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$300M−$200M−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$49.8M−$50.3M
FY24$6M−$200.4M
FY23$1.1M−$177.1M
FY22$0−$101.9M
FY21$0−$87.8M
FY20$23.4M−$58.6M
FY19$32.3M$130.1M
FY18$26.6M−$120.5M
FY17$15.9M−$123M
FY16$0−$131.4M
FY15$130M−$4.7M
FY14$22.9M−$100.3M
FY13$2.2M−$104.1M
FY12$1.1M−$110.2M
FY11$1.8M−$116.2M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2599.4%−98.2%−101.1%
FY2489.7%−3284.7%−3339.5%
FY2392.3%−15473%−15956.7%
FY22---
FY21---
FY2091.8%−204.2%−250.3%
FY1990%437.5%402.5%
FY1890.6%−388.5%−453.5%
FY1788%−822.1%−774%
FY16---
FY15100%1.1%−3.6%
FY14-−439.2%−438.8%
FY13-−4607.2%−4686.1%
FY12-−9955.5%−10120.4%
FY11-−6170.6%−6285.3%
Free cash flowOperating cash flow minus capital expenditure
−$200M−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$67.9M
FY24−$179.8M
FY23−$162.4M
FY22−$90.2M
FY21−$88.2M
FY20−$143.1M
FY19$113.7M
FY18−$148.7M
FY17−$185.6M
FY16−$175.9M
FY15$183.9M
FY14−$75.7M
FY13−$92.8M
FY12−$95M
FY11−$89.1M
Returned to shareholdersDividends paid and shares bought back
$0$1M$2M$3MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24$1.7M
FY23$824K
FY22$864K
FY21$2.7M
FY20$1M
FY19$941K
FY18$972K
FY17$1.7M
FY16$621K
FY15$357K
FY14$887K
FY13$873K
FY12$285K
FY11$108K
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Lexicon Pharmaceuticals
  • Healthcare median
−20000%−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearLexicon PharmaceuticalsHealthcare median
FY25−101.1%−30.6%
FY24−3339.5%−47%
FY23−15956.7%−58%
FY22-−80.4%
FY21-−71.8%
FY20−250.3%−62.2%
FY19402.5%−46.2%
FY18−453.5%−49.6%
FY17−774%−45.9%
FY16-−36%
FY15−3.6%−37.8%
FY14−438.8%−35.5%
FY13−4686.1%−37.1%
FY12−10120.4%−29.1%
FY11−6285.3%−27.9%